Supplementary Table I: Primer sequences

Name / Sequence / Reference
Genotyping
Primer 1 / gtagccaaagatgaccttg
Primer 2 / gctttcctttctgcttttacatttc
Primer 3 / ctgccggagttgcaaggtaagctgg
Primer 4 / gtgtctgttggaagcaggagttc
Real-time rt-pcr
18S rRNA Fwd / gtaacccgttgaaccccatt
18S rRNA Rev / ccatccaatcggtagtagcg
Ciita HA Fwd / cgacggaccatggagtacccatat
Ciita HA Rev / ggagttccaggtagctgccctctg
Ciita Total Fwd / aagagaaggctggaaggatcttt / 71
Ciita Total Rev / gatgtggaagacctggatcgt / 71
Ciita I Fwd / aagagctgctctcacgggaat / 10
Ciita III Fwd / tcttacctgccggagtt / 10
Ciita IV Fwd / gagactgcatgcaggcagca / 10
Ciita Rev / ggtcggcatcactgttaagga / 10
Col1A1 Fwd / AAGGTGACAGAGGCATAAAGG
Col1A1 Rev / TTGAGTCCGTCTTTGCCAG
Cste Fwd / CCAGACCTTTGTGAATGCAG
Cste Rev / GTCATAGCCTCCGAAAGTCAG
H2-D1 Fwd / CCCTGACCTGGCAGTTGAATG
H2-D1 Rev / AGCTCCAAGGATGACCACAGC
H2-DOa Fwd
H2-DOa Rev / CCGCAATGAGCTTCCTGAGTC
TGTTCCCCGTCAAATTCGTG
H2-DOb Fwd / TCAGGCAAGGCGGACTGTTAC / 72
H2-DOb Rev / TCCTCTCTGGATACACTGTCACCTC
H2-DMa Fwd / TGAAGGTCAAATCCCAGTGTCC / 72
H2-DMa Rev / AGCGGTCAATCTCGTGTGTCAC
H2-DMb Fwd / GTCCTCAGTCTGCACTGTATG
H2-DMb Rev / CAGCACCCCAAATTCACAG
IA alpha Fwd / cttcccacctgtgatcaacat
IA alpha Rev / aatctcaggttcccagtgttt
Ii Fwd / GTGTCTGTTTCATCGTCCCAG / 73
Ii Rev / AAGGCAGCAAATGTGTCCAGC / 73
Kiaa0841 Fwd / TGAAAGACACCCAGCATCG
Kiaa0841 Rev / ACAGGTCCAAAGGTCACATC
Kpna6 Fwd / aatccctactgtggcctcatc
Kpna6 Rev / gctgtcgtcatcctctacacca
Plxna1 Fwd / caatcctgctaccgtggagaa / 26
Plxna1 Rev / ccgcagaagtcgtcatcaat / 26
Psmd3 Fwd / GTATCCAAGTCTGTGTTCCCTG
Psmd3 Rev / CTCTACCACGATCAGAAGCTTG
Rab4b Fwd / TGGCGACATATCCCTCCGCC
Rab4b Rev / ACAGGTGAGCTGGTTCTGCACAT
Tpp1 Fwd / AGGACTTTCTGACTTGCTGG
Tpp1 Rev / CCCCACAAAATCCACATGAG
Trim26 Fwd / TCTGAACCACTTGAACACCC
Trim26 Rev / TGGCCCTGCTTAAATTCCG
5’ RACE
5’RACE inner / GGTCATAGAGGTGGTAGAGATGTAGG
5’RACE outer / TGATGGTATCTGTGTCTGGCTCTG
Cloning
D5’d, XhoI / gggCTCGAGcttcctcatatctcagtgaaa
D3’, ClaI / gggATCGATgtgatggttttgcatctgct
C5’, ClaI / gccATCGATgaagttcctattccgaagttcctattctctagaaagtataggaacttcttccccaagtgagctacagt
C3’, SalI / gcgGTCGACggcagtgctctgaggctgcctgct
B5’, SalI / gagGTCGACggaccatggagtacccatatgacgttccagactacgcgcgctgcctggttcctgg
B2-5’OL / ctgccggagttgc aaggtaagctggcatc
B1-3’OL / taccttgcaactccggcag
B2-3’, XhoI / gccCTCGAGgaagttcctatactttctagagaataggaacttcggaataggaacttcaagctttgtgcttgcaG
A5’, NotI / gggGCGGCCGCtttccacattgatcagagcat
A3’, SacII / gggCCGCGGcacctcagacaccagcctt

Supplemental References

71. Green MR, Yoon H, Boss JM. Epigenetic regulation during B cell differentiation controls CIITA promoter accessibility. J. Immunol. 2006; 177(6): 3865-73.

72. Porter GW, Yi W, Denzin LK. TLR agonists downregulate H2-O in CD8alpha- dendritic cells. J. Immunol. 2011; 187(8): 4151-60.

73. Itoh-Lindstrom Y, Piskurich JF, Felix NJ, Wang Y, Brickey WJ, Platt JL et al. Reduced IL-4-, lipopolysaccharide-, and IFN-gamma-induced MHC class II expression in mice lacking class II transactivator due to targeted deletion of the GTP-binding domain. J. Immunol. 1999; 163(5): 2425-31.